You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《瑞通窝轮》【瑞通认股证牛熊证】瑞声、舜宇齐向上突破 石药见死亡交叉讯号 瑞声购18945 熊68083/ 舜光牛62461 熊56519/ 石药牛63136 熊63134
阿思达克 12-06 10:32

美国总统特朗普指中美两国目前的贸易谈判进展顺利。道指隔晚收报27677点,升28点(或0.1%)。恒指昨收报26217点,升154点(或0.6%)。今早继续向上,升逾250点,上试26500点。恒指好仓(牛证及认购权证)昨净流出近2000万港元(下同),恒指淡仓(熊证及认沽权证)同日净流入逾2600万元,反映投资者预期港股反弹告终。昨日恒指牛证街货重货区为收回价25900至25992点,而熊证街货重货区为收回价26600至26699点。

瑞声(02018)昨急升6.8%收市,为升幅最大蓝筹,一举收复10天和20天线。瑞声今早再升近8%,升穿60元关口,突破上月高位阻力,亦创超过9个月高位。昨有逾230万元净流出其好仓,淡仓同日则有78万元净流入。另一手机设备股舜宇(02382)继昨日抽升半成後,今早继续向上,升超过4%,高见138元,突破上月上旬的顶位,再上阻力参考去年6月底上落区间顶位约147元。昨日逾110万净流出舜宇好仓,而其淡仓同日有超过270万净流入。

上周急挫的石药(01093)有喘稳迹像,昨以1.6%升幅跑赢大市,盘中高位重上17.8元,结束两日跌势。以昨日收市价17.74元计,股份自近日低位反弹3%,但自上月所创的52周高位21.8元累泻逾18%,14日RSI回落至40以下。石药今早大致靠稳,首个阻力留意18元关口。技术上,10天线跌穿50天线,出现死亡交叉讯号。昨分别有19万元和23万元净流出其好仓和淡仓。

石油输出国组织与盟友今周召开会议讨论延长减产,消息指沙特及俄罗斯建议扩大减产力度,加上美国原油库存六周以来首度回落,带动国际油价连日向上,中海油(00883)昨收升1.2%於11.3元,不过尚未扭转近日反覆回落走势。中海油今早续於11.3元之上徘徊,但仍受制多条移动平均线。昨有逾470万元净流入其好仓,淡仓则未见明显资金流。

有券商估计内地保险业将迎来更多产品及分销渠道的改革,料行业增长保持适度。国寿(02628)昨升1.33%,报19.74元,收复50天线,今早升约2%,升穿20元关口,若能自10月上旬後首度企稳10天线20.05元之上,可视为技术走势好转,近期低位19.36元或具支持力度。昨有近60万元净流出其好仓,淡仓同日则有6万元净流入。

瑞通相关认股证之选择:

瑞声贴价、中短期购18945,行使价:56.9元,2020年4月到期,实际杠杆:4.3倍

舜光轻微价外、中短期购28734,行使价:148.8元,2020年5月到期,实际杠杆:5倍

舜光轻微价外、中年期沽12845,行使价:110.8元,2020年6月到期,实际杠杆:3.2倍

石药轻微价外、短期购25482,行使价:19.8元,2020年3月到期,实际杠杆:7倍

石药价外、中年期沽28344,行使价:14.68元,2020年7月到期,实际杠杆:3.6倍

海油轻微价外、短期购22652,行使价:12.38元,2020年1月到期,实际杠杆:14.6倍

国寿轻微价外、中年期购27927,行使价:21.3元,2020年6月到期,实际杠杆:7.3倍

国寿贴价、中短期沽12348,行使价:19元,2020年5月到期,实际杠杆:6倍

腾讯轻微价外、中短期购11867,行使价:352.7元,2020年3月到期,实际杠杆:10.7倍

腾讯贴价、短期沽27548,行使价:320.7元,2020年2月到期,实际杠杆:13.1倍

瑞通相关牛熊证之选择:

恒指N类牛证58812,收回价:25820点,杠杆比率:36.7倍

恒指熊证63129,收回价:27043点,杠杆比率:34.8倍

瑞声熊证68083,收回价:61.9元,杠杆比率:12倍

舜光牛证62461,收回价:118.8元,杠杆比率:5.4倍

舜光熊证56519,收回价:146.9元,杠杆比率:8.9倍

石药牛证63136,收回价:16.2元,杠杆比率:7.6倍

石药熊证63134,收回价:19.3元,杠杆比率:7.1倍

海油牛证61259,收回价:10.5元,杠杆比率:10.2倍

海油熊证63152,收回价:12.3元,杠杆比率:8.2倍

国寿牛证62695,收回价:18.9元,杠杆比率:11.5倍

国寿熊证62746,收回价:21元,杠杆比率:14倍

美团牛证62230,收回价:97.51元,杠杆比率:10.5倍

美团熊证62736,收回价:105.7元,杠杆比率:13.7倍重要风险通知

本结构性产品并无抵押品。

结构性产品之价格一般可急升亦可急跌,有可能损失结构性产品之全部或重大部分购买价,阁下对此应有所准备。

阁下投资前应了解产品风险,如有需要应谘询专业建议。~重要声明:

以上资讯由第三方提供,AASTOCKS.com Limited对於任何包含於、经由、连结、下载或从任何与本网站有关服务所获得之资讯、内容或广告,不声明或保证其内容之正确性或可靠性。对於您透过本网站上之广告、资讯或要约而展示、购买或取得之任何产品、资讯资料,本公司亦不负品质保证之责任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account